Dow down 0.36% Nasdaq down 0.53%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}
 Dow down 0.36% Nasdaq down 0.53%
{"s" : "^dji,^ixic","k" : "p20","o" : "","j" : ""}

Quote Results

Add Quotes

SymbolTime & PriceChg & % ChgDay's Low & HighVolumeAvg VolMkt CapChartMore Info
Sep 12 22.64 -1.00 -4.23% 22.64 22.64 403 2,548 41.5B Sparkline Chart Chart, News, Stats, Board
No such ticker symbol: AMX.MXTry Symbol Lookup
No such ticker symbol: SSNLF.KSTry Symbol Lookup
Sep 12 75.64 -0.47 -0.62% 75.60 76.12 21,203 32,727 241.37B Sparkline Chart Chart, News, Stats, Board
Sep 12 48.15 +1.43 +3.05% 47.30 48.20 283 11,394 126.58B Sparkline Chart Chart, News, Stats, Board
No such ticker symbol: SHPTry Symbol Lookup
Sep 12 81.40 +4.42 +5.74% 78.50 81.77 148,356 29,641 96.74B Sparkline Chart Chart, News, Stats, Board
Sep 2 22.00 0.00 0.00% - - 0 0 8.89M Sparkline Chart Chart, News, Stats, Board
Sep 12 111.14 -0.87 -0.78% 111.01 111.51 163,499 14,830 178.58B Sparkline Chart Chart, News, Stats, Board
Sep 12 74.70 -0.39 -0.52% 74.47 75.36 2,116,924 2,100,670 40.46B Sparkline Chart Chart, News, Stats, Options, Board
{"s" : "mtnof,nsrgf,nonof,sftbf,ictg,ahbif,bax","k" : "t53,l84,c63,p43,g53,h53,v53,j10,c63,l84,p43,a00,a50,b00,b60,g00,h00,t53,v53","o" : "","j" : "c63,l84,p43,t53,v53"}

Quotes delayed, except where indicated otherwise.

Recent News

day and time symbols news headline and source
SABMiller tops FTSE on takeover talk at Financial Times04:39am EDT
2:25 am Baxter approves Baxter's HYQVIA for treatment of adults with primary immunodeficiency Briefing.com02:25am EDT
Heineken rejects takeover in bid to stay independent at CNNMoney.com01:06am EDT
Sunday September 14, 2014
SABMiller rebuffed by Heineken at Financial Times06:14pm EDT
Friday September 12, 2014
FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency Business Wire07:02pm EDT
[video] Other ways to own Alibaba ahead of IPO at CNBC04:26pm EDT
Thursday September 11, 2014
Momenta Gains on Purchase of Autoimmune Antibodies Zacks04:45pm EDT
Baxter Names its New Spun-off Biopharmaceuticals Company Zacks12:50pm EDT
Scientists unlock secrets of coffee DNA at Financial Times04:06am EDT
Wednesday September 10, 2014
Microsoft Sees More Than Fun in a Game Like Minecraft at New York Times08:52pm EDT
Baxter Announces Baxalta as the Name of New Global Biopharmaceutical Company Business Wire04:30pm EDT
Tuesday September 9, 2014
Alibaba IPO: Is it too late to get rich with Jack Ma? at MarketWatch01:08am EDT
Monday September 8, 2014
Why Baxter International Offers Great Reward for Minimal Risk at TheStreet06:00am EDT
Friday September 5, 2014
Alibaba Group Values IPO At Up To $162.7 Billion Benzinga04:20pm EDT
Wednesday September 3, 2014
FTSE 100 jumps toward record close on Ukraine prospects at MarketWatch12:16pm EDT
Baxter Expects to Grow on Acquisitions and Product Lineups Zacks12:10pm EDT
Vietnam's Hottest Stock -- and You Can Slurp It at TheStreet11:18am EDT
Ukraine crisis puts palm oil price in a slide at Financial Times02:00am EDT
Tuesday September 2, 2014
Baxter Will Remain Diversified and With Competitive Advantages Gurufocus02:49pm EDT
How Will Vodafone (VOD) Stock React To Possible SoftBank (SFTBF) Bid? at TheStreet12:43pm EDT
How Will American Movil (AMX) Stock React To Sale of Phone Assets? at TheStreet08:58am EDT
Wednesday August 27, 2014
Ebola a long term 'blip' for Africa investors at CNBC12:45pm EDT
Friday August 22, 2014
Positive Data on Baxter's Trial for BAX 855 Zacks05:30pm EDT
Thursday August 21, 2014
Long-acting version of Baxter's hemophilia drug succeeds in study Reuters10:41am EDT
Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients Business Wire09:00am EDT